Back
Avidity Biosciences 10K Form
Sell
24
RNA
Avidity Biosciences
Last Price:
46.32
Seasonality Move:
20.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RNA News And Ratings
See the #1 stock for the next 7 days that we like better than RNA
RNA Financial Statistics
Sales & Book Value
Annual Sales: | $9.56M |
---|---|
Cash Flow: | $-65.54M |
Price / Cash Flow: | 0 |
Annual Sales: | $11.17 |
Price / Book: | 4.44 |
Profitability
EPS (TTM): | -2.95000 |
---|---|
Net Income (TTM): | $-252.45M |
Gross Margin: | $8.9M |
Return on Equity: | -34.78% |
Return on Assets: | -30.7% |
Avidity Biosciences Earnings Forecast
Key Avidity Biosciences Financial Ratios
- The Gross Profit Margin over the past 1 years for RNA is 100.00%.
- The Selling, General & Administrative Expenses for RNA have been equal to 566.84% of Gross Profit Margin.
- The Research & Development expenses have been 1,997.57% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of RNA is -2,219.87% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 1 years.
Avidity Biosciences Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | RNA |
CUSIP: | 05370A |
Website: | aviditybiosciences.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 15.78 |
Quick Ratio: | 15.61 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
RNA Technical Analysis vs Fundamental Analysis
Sell
24
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy or a Sell?
-
Avidity Biosciences stock is rated a Sell
The current Avidity Biosciences [RNA] share price is $46.30. The Score for RNA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.